| Vial description: |
35-alpha calcimedin, Annexin IIIAP-III, Annexin-3, Lipocortin III, ANX3 |
| Category: |
primary antibody |
| Raised in: |
Rabbit |
| Clone: |
1 vial |
| Form: |
Purified |
| Reactivity: |
Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P12429 |
| Application: |
Western Blot, ELISA |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
Annexin A3 / ANXA3 |
| Short name: |
anti-Annexin A3 / ANXA3 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
antibody to-Annexin A3 / annexin A3 (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ANX3, ANXA3 and IDBG-26122 and ENSG00000138772 and 306, ANXA3 and IDBG-643150 and ENSBTAG00000010153 and 518050, Anxa3 and IDBG-181899 and ENSMUSG00000029484 and 11745, Plasma membranes, calcium-dependent protein binding, this GO :0004859 and phospholipase inhibitor activity and molecular function this GO :0005509 and calcium ion binding and molecular function this GO :0005544 and calcium-dependent phospholipid binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006909 and pha this GO cytosis and biological process this GO :0010595 and positive regulation of endothelial cell migration and biological process this GO :0016020 and membrane and cellular component this GO :0019834 and phospholipase A2 inhibitor activity and molecular function this GO :0030670 and pha this GO cytic vesicle membrane and cellular component this GO :0042581 and specific granule and cellular component this GO :0042742 and defense response to bacterium and biological process this GO :0043086 and negative regulation of catalytic activity and biological process this GO :0043312 and neutrophil degranulation and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0048306 and calcium-dependent protein binding and molecular function this GO :0051091 and positive regulation of sequence-specific DNA binding transcription factor activity and biological process this GO :0070062 and extracellular vesicular exosome and cellular component, this GO :0004859 : phospholipase inhibitor activity, this GO :0004859 : phospholipase inhibitor activity and also this GO :0005509 : calcium ion binding and also this GO :0005544 : calcium-dependent phospholipid binding and also this GO :0019834 : phospholipase A2 inhibitor activity and also this GO :0048306 : calcium-dependent protein binding, this GO :0005509 : calcium ion binding, this GO :0005544 : calcium-dependent phospholipid binding, this GO :0019834 : phospholipase A2 inhibitor activity, this GO :0048306 : calcium-dependent protein binding, annexin A3 |
| Identity: |
541 |
| Gene: |
ANXA3 |
More about : ANXA3 |
| Long gene name: |
annexin A3 |
| Synonyms gene: |
ANX3 |
| Locus: |
4q21, 21 |
| Discovery year: |
1990-11-07 |
| GenBank acession: |
M63310 |
| Entrez gene record: |
306 |
| Pubmed identfication: |
1830024 |
| RefSeq identity: |
NM_005139 |
| Classification: |
Annexins |
| Havana BLAST/BLAT: |
OTTHUMG00000130198 |